Update of PDE5 inhibitors for the treatment of ischemia-reperfusion.
- Author:
Yang-Yang HU
1
;
Zhi-Gang WU
Author Information
1. Department of Urology, The First Hospital Affiliated to Wenzhou Medical College, Wenzhou, Zhejiang 325000, China. huyangyang0577@126.com
- Publication Type:Journal Article
- MeSH:
Erectile Dysfunction;
drug therapy;
Humans;
Male;
Phosphodiesterase 5 Inhibitors;
therapeutic use;
Phosphodiesterase Inhibitors;
therapeutic use;
Reperfusion Injury;
drug therapy
- From:
National Journal of Andrology
2011;17(9):842-846
- CountryChina
- Language:Chinese
-
Abstract:
Phosphodiesterase type 5 (PDE5) inhibitors are used most commonly in the treatment of penile erectile dysfunction (ED). Recent studies show that PDE5 inhibitors are ideal drugs for treating ischemia-reperfusion injury. This review focuses on the results of basic and clinical researches on PDE5 inhibitors for the treatment of ischemia-reperfusion injury and provides some theoretical evidence for clinical options of the drugs.
